Press Releases

 Filter by Provider

Article explores how citizenship-based obligations can affect tax, estate, mobility, and long-term financial planning for families with ties to Canada and the United States

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Csquare, Inc. (“Csquare” or “the Company”) (NYSE: CSQR) for violations of the securities laws.

LOS ANGELES, Oct. 25, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Flotek Industries, Inc. (“Flotek” or “the Company”) (NYSE: FTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Choosing a place to live in Charleston comes with plenty of charm to weigh. There are tree-lined streets climbing the hillsides, views of the Kanawha River, and neighborhoods with a real sense of history. It’s easy to fall in love with a front porch before ever checking a statistic.

The first time you see your own company named inside an AI answer, the reaction is usually suspicion. You assume you phrased the prompt in a way that fished for it. So you rephrase, open a clean session, try a different engine, and it happens again. Somewhere along the line you stop treating it as a fluke.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TTM Technologies, Inc. (“TTM” or “the Company”) (NASDAQ: TTMI) for violations of the securities laws.

Austin's Honnas Veterinary details the internal process it uses to turn client feedback, both good and bad, into staff training and better care.

Program connects firms with recent, record-verified motor vehicle accident claimants who asked for legal help, delivered as a live call to the firm's intake team or as a complete file with engagement documents already signed

— ORPATHYS® plus TAGRISSO® reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO® —

Approved merchants buy Sentrix films at merchant pricing and receive customer leads at no additional charge.

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF,” or the “Company”), a California-based global Embodied AI (“EAI”) ecosystem company, today announced that this week’s Investor Weekly Report from FF Founder and Global CEO YT Jia has been rescheduled to October 26.

Ask Fed Fran expands education on TSP, FERS, PSHB, Medicare Part B, and beneficiary reviews for federal and postal employees.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Fibroid Institute opens its newest fibroid clinic to serve the Greater Heights and Memorial Heights areas of Houston, Texas. With additional locations, this specialized concierge medical practice provides local access to care for thousands of women seeking non-surgical relief from fibroids.

Wall Street's October optimism meets a disciplined search for a domestic lithium footprint

ELEKTROS studies a property near Canada as American automakers and battery makers seek resilient supply chains

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of securities of Celsius Holdings, Inc. (NASDAQ: CELH) between February 21, 2025 and June 3, 2026. Celsius describes itself as a company that “develops, processes, manufactures, markets, sells, and distributes products including energy drinks.”

Potential relief from overseas shipping complexity brings a fresh dimension to the ELEK story

Alexis 420's 50-state guide shows tourists 21 and older can buy cannabis in 23 states, visiting patients in 10 more plus DC and no visitors in 17, ahead of Thanksgiving and year-end holiday travel.

United States, October 25, 2026 -- As digital healthcare continues to reshape how individuals access medical services, FORA VIV is highlighting a more convenient and personalized approach to wellness through its online telehealth platform. By connecting eligible patients with licensed healthcare providers, the company aims to simplify access to individualized care across weight management, sexual health, wellness, and skincare.

NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) --

With dizziness affecting roughly 40% of neck pain patients, Singapore’s Dr Neck Pain has announced an X-ray-guided program that targets cervicogenic dizziness at its structural source in the upper cervical spine.

BIWEEKLY REVIEWS releases guide for launching longarm quilting businesses, detailing machine costs from $1,250 to $42,999, space requirements, service pricing models, equipment comparisons, and business planning essentials for aspiring quilting entrepreneurs.

For over 60 years, Rentco has been serving the Peace Region with tool and equipment rentals, sales and services. Visit one of our multiple locations today!

The recognition underscores M bank's continued focus on digital banking innovation, as Global Finance honors the neobank for the second consecutive year.

MicroVision, Inc. (NASDAQ: MVIS), a leader in advanced perception solutions for industrial, security and defense, intelligent infrastructure, and automotive applications, today announced the much-anticipated commercial production launch of MOVIA™ Pro, shipping sensors to meet customer demand.

Aratea Dental Clinic in Lahug, Cebu City, compares veneers and teeth whitening, outlining cost, longevity, and suitability differences to help patients choose confidently after a proper dental assessment with Dr. Ma. Chona Aratea-Fajardo.

MENLO PARK, Calif., Oct. 25, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis (PsO) and hidradenitis suppurativa (HS), today announced it will report Week 16 data for ORKA-001 from the ongoing EVERLAST-B Phase 2b trial in moderate-to-severe plaque psoriasis on Monday, October 26, 2026. Following the announcement, the company will host a conference call and webcast at 8:00 a.m. ET to discuss the results.

Summit Therapeutics Inc. (Nasdaq: SMMT) today noted that its partner Akeso Inc. announced positive results from the Phase III HARMONi-GI1 study evaluating the novel, potential first-in-class investigational bispecific antibody ivonescimab plus chemotherapy compared with durvalumab plus chemotherapy as a first-line treatment for patients with advanced biliary tract cancer (BTC). These data are featured in today’s Presidential Symposium II at the European Society for Medical Oncology 2026 Congress (ESMO 2026) in Madrid, Spain.

Positive results from the CLARITY-Gastric01 global Phase III trial showed AstraZeneca’s sonesitatug vedotin (Sone-Ve) demonstrated a statistically significant and highly clinically meaningful improvement in overall survival (OS) in 2nd- and later-line Claudin 18.2-positive advanced gastric cancers versus investigator’s choice of therapy.

Positive results from the SAFFRON Phase III trial showed TAGRISSO® (osimertinib) plus savolitinib demonstrated a statistically significant and clinically meaningful improvement in both progression-free survival (PFS) and overall survival (OS) versus doublet platinum-based chemotherapy in patients with epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). Patients in the trial had tumors with high levels of MET overexpression or amplification and had progressed on prior treatment with TAGRISSO.

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today pivotal results from the Phase III Krascendo 1 study, which demonstrated the superior efficacy of investigational divarasib, a next-generation KRAS G12C inhibitor, compared with current standard of care KRAS G12C inhibitors in people with previously treated KRAS G12C-mutated non-small cell lung cancer (NSCLC). Participants treated with divarasib monotherapy lived significantly longer, lowering the risk of death by 44% compared with sotorasib or adagrasib (overall survival, OS, HR 0.56, [95% CI: 0.41-0.78], p=0.0005). Median OS for divarasib is currently approximately 18 months, compared to 12 months for the control arm (see table below). No new safety findings were observed with divarasib and the most common treatment-related adverse events (TRAEs) were mainly low grade and manageable. These data were presented as a late-breaking abstract during a Presidential Symposium at the 2026 European Society for Medical Oncology (ESMO) Congress and simultaneously published in The New England Journal of Medicine.

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026. Hims describes itself as a company that “operates a health and wellness platform that connects consumers to licensed healthcare professionals.”

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Shifting from "Database" to "Living Exhibition", Building a New Landmark for the Preservation and Inheritance of Linguistic and Cultural Heritage

New York, USA, October 25, 2026 -- As Halloween approaches, AVIDLOVE is highlighting versatile fashion pieces that inspire creative seasonal styling. Guided by its brand philosophy, “Confidence is Your Stage,” the brand celebrates personal expression through contemporary designs, comfortable materials, and adaptable wardrobe options. From themed celebrations to everyday outfits, AVIDLOVE encourages fashion enthusiasts to explore new combinations and make their seasonal style uniquely their own.

Updated Results Show Deep and Durable Responses in High-Risk, Heavily Pretreated Multiple Myeloma, Supporting Further Development of the Company’s TCE Pipeline

K-38 Consulting releases a startup guide and downloadable 13-week cash flow forecast template, helping founders project near-term cash, spot potential shortfalls, and update their outlook weekly.

The wellness brand develops easy-to-use massage and recovery products designed for real-life routines at home, at work, and on the go.

The Boxery of Lyndhurst, NY, outlines how recyclable, lighter-weight affordable mailers can help ecommerce brands reduce packaging waste and respond to growing customer expectations for sustainable shipping.

NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) --

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Flotek Industries To Contact Him Directly To Discuss Their Options

NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) --